Matrix Capital Management Company, LP

ZNTL

Matrix Capital Management Company, LP serves as 10% Owner at Zentalis Pharmaceuticals, Inc. (ZNTL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$107.86M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$107.86M

Companies Traded

ZNTL

Active Period

Jun 2023

1 total trades

Most Recent

Buy ZNTL

Jun 20, 2023 · $107.86M

Matrix Capital Management Company, LP's Insider Trading at Zentalis Pharmaceuticals, Inc. (ZNTL)

Buys

1 · $107.86M

Sells

0 · $0.00

Total Shares Bought

4,760,000

Total Shares Sold

ZNTL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 20, 2023	Buy	4,760,000	$22.66	$107.86M	13,959,973

Related Insiders

Ingmar Bruns

officer: Chief Medical Officer

ZNTLSell · Feb 10, 2026

EASTLAND JULIA MARIE

director, officer: CEO & President

ZNTLSell · Feb 10, 2026

Vultaggio Vincent

PAO and PFO

ZNTLSell · Feb 10, 2026

WALTERS GROUP

10% Owner

ZNTLBuy · Dec 31, 2025

Scott Dunseth Myers

Director

ZNTLBuy · Apr 30, 2025

Explore More Insider Trading Data

ZNTL Insider Trading Activity

View all insider trades at Zentalis Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity